Stanford researchers have developed a personalized arrhythmia risk prediction tool for dilated cardiomyopathy (DCM) patients using patient-derived induced pluripotent stem cells (iPSCs) to replicate heart biology and accurately predict arrhythmia risk, enabling timely interven
Stanford scientists have discovered novel high molecular weight isoforms of thymic stromal lymphopoietin (TSLP), measured using nanoimmunoassay (NIA), that can serve as a blood-based biomarker for the diagnosis and prognostication of acute graft versus host disease (aGVHD).
Researchers from Stanford have developed a novel topical pharmaceutical composition comprising of a chemical inhibitor encapsulated in nanomicelles for the treatment of vision loss associated with acute optic neuropathies.
Researchers at Stanford, in collaboration with UCSF, have developed a two-part approach to preventing preterm birth (PTB), the leading cause of infant mortality worldwide. Current treatments, like low-dose aspirin and progesterone, are limited and often ineffective.
Researchers at Stanford have created the first small primate model to study human heart rhythm disorders and also discovered a new way the heart keeps its beat.
Researchers at Stanford University have developed a compact insulin pump for continuous subcutaneous insulin infusion (CSII) that addresses a core limitation of many commercial pumps: device size driven by piston-based mechanics.
Stanford University researchers in the Bamm and Durmus Labs have developed the Dynamic AI-Driven Raman Techniques (DART) platform, which integrates electrochemical enhancement with surface-enhanced Raman spectroscopy for real-time, sensitive, specific, reproducible biomarker d
Over 1 in 3 people are affected by neurological conditions worldwide. Pharmacological and surgical treatment options may be limited due to access, side effects, and reduced therapeutic efficacy.
Stanford researchers have developed a new therapeutic approach to protect neurons and promote axon regeneration by restoring mitochondrial transport within axons, a key process disrupted in many neurodegenerative diseases.
Stanford scientists have developed a lightweight, wearable multichannel NMES system that provides real-time, AI-driven gait assistance and muscle strengthening — with a particular focus on children with walking disabilities.
Stanford researchers in the CHARM Lab have developed a compact pneumatic control system for precise pressure modulation in for wearable, multi-device haptic systems and smart textiles.
Stanford researchers have designed a electrochemical sensor system for continuous analyte measurement and tracking in complex biological samples (i.e. blood and serum) with a wide range of clinical and non clinical applications.
Stanford researchers have found a way to predict an individual's remaining lifespan directly from routinely collected longitudinal electronic health records, enabling faster and more accurate decision-making for life insurance underwriting, reinsurance, and clinical planning.